183 related articles for article (PubMed ID: 10483867)
1. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint.
Marx F; Blasko I; Grubeck-Loebenstein B
Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867
[TBL] [Abstract][Full Text] [Related]
2. The possible role of the immune system in Alzheimer's disease.
Marx F; Blasko I; Pavelka M; Grubeck-Loebenstein B
Exp Gerontol; 1998; 33(7-8):871-81. PubMed ID: 9951630
[TBL] [Abstract][Full Text] [Related]
3. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
4. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
6. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
[TBL] [Abstract][Full Text] [Related]
7. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
Weiner HL; Lemere CA; Maron R; Spooner ET; Grenfell TJ; Mori C; Issazadeh S; Hancock WW; Selkoe DJ
Ann Neurol; 2000 Oct; 48(4):567-79. PubMed ID: 11026440
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
9. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease pathogenesis and therapeutic interventions.
Parihar MS; Hemnani T
J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
[TBL] [Abstract][Full Text] [Related]
11. The role of inflammation in Alzheimer's disease.
Tuppo EE; Arias HR
Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
[TBL] [Abstract][Full Text] [Related]
12. Immunity and neuronal repair in the progression of Alzheimer's disease: a brief overview.
Baron R; Harpaz I; Nemirovsky A; Cohen H; Monsonego A
Exp Gerontol; 2007; 42(1-2):64-9. PubMed ID: 17074458
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
15. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
17. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
18. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
Shepherd CE; Gregory GC; Vickers JC; Halliday GM
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
[TBL] [Abstract][Full Text] [Related]
19. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K
Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927
[TBL] [Abstract][Full Text] [Related]
20. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
